“…Levine:Prelude Therapeutics: Research Funding; Qiagen: Current equity holder in publicly-traded company, Membership on an entity’s Board of Directors or advisory committees; Loxo: Current equity holder in private company, Membership on an entity’s Board of Directors or advisory committees; Imago: Current equity holder in private company, Membership on an entity’s Board of Directors or advisory committees; C4 Therapeutics: Current equity holder in private company, Membership on an entity’s Board of Directors or advisory committees; Isoplexis: Current equity holder in private company, Membership on an entity’s Board of Directors or advisory committees; Celgene: Consultancy, Honoraria, Research Funding; Roche: Consultancy, Honoraria, Research Funding; Lilly: Consultancy, Honoraria; Janssen: Consultancy; Astellas: Consultancy; Morphosys: Consultancy; Novartis: Consultancy; Amgen: Honoraria; Gilead: Honoraria. …”
Enlace del recurso
Enlace del recurso

“…DISCLOSURES: Matthew Sims, MD, PhD, FACP, FIDSA, Astra Zeneca (Independent Contractor)Diasorin Molecular (Independent Contractor)Epigenomics Inc (Independent Contractor)Finch (Independent Contractor)Genentech (Independent Contractor)Janssen Pharmaceuticals NV (Independent Contractor)Kinevant Sciences gmBH (Independent Contractor)Leonard-Meron Biosciences (Independent Contractor)Merck and Co (Independent Contractor)OpGen (Independent Contractor)Prenosis (Independent Contractor)Regeneron Pharmaceuticals Inc (Independent Contractor)Seres Therapeutics Inc (Independent Contractor)Shire (Independent Contractor)Summit Therapeutics (Independent Contractor) Sahil Khanna, MBBS, MS, Seres (Grant/Research Support) Darrell Pardi, MD, seres (Consultant)Vedanta (Consultant) Paul Feuerstadt, MD, FACG, Ferring/Rebiotix Pharmaceuticals (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Finch Pharmaceuticals (Scientific Research Study Investigator)Merck and Co (Speaker's Bureau)SERES Therapeutics (Consultant, Scientific Research Study Investigator)Takeda Pharmaceuticals (Consultant) Elaine E. …”
Enlace del recurso
Enlace del recurso

“…Fowler, Jr., MD, MHS, Achaogen (Consultant)Advanced Liquid Logics (Grant/Research Support)Affinergy (Consultant, Grant/Research Support)Affinium (Consultant)Akagera (Consultant)Allergan (Grant/Research Support)Amphliphi Biosciences (Consultant)Aridis (Consultant)Armata (Consultant)Basilea (Consultant, Grant/Research Support)Bayer (Consultant)C3J (Consultant)Cerexa (Consultant, Other Financial or Material Support, Educational fees)Contrafect (Consultant, Grant/Research Support)Debiopharm (Consultant, Other Financial or Material Support, Educational fees)Destiny (Consultant)Durata (Consultant, Other Financial or Material Support, educational fees)Genentech (Consultant, Grant/Research Support)Green Cross (Other Financial or Material Support, Educational fees)Integrated Biotherapeutics (Consultant)Janssen (Consultant, Grant/Research Support)Karius (Grant/Research Support)Locus (Grant/Research Support)Medical Biosurfaces (Grant/Research Support)Medicines Co. …”
Enlace del recurso
Enlace del recurso

“…(Advisor or Review Panel member, Research Grant or Support)Infectious DIseases Connect (Other Financial or Material Support, Share Options)Janssen (Consultant)Merck (Consultant) Rima Abdel-Massih, MD, Infectious Disease Connect (Employee, Director of Clinical Operations) Rima Abdel-Massih, MD, Infectious Disease Connect (Individual(s) Involved: Self): Chief Medical Officer, Other Financial or Material Support, Other Financial or Material Support, Shareholder…”
Enlace del recurso
Enlace del recurso

“…Englund, MD, AstraZeneca (Consultant, Grant/Research Support)GlaxoSmithKline (Research Grant or Support)Meissa Vaccines (Consultant)Pfizer (Research Grant or Support)Sanofi Pasteur (Consultant)Teva Pharmaceuticals (Consultant) Michael Boeckh, MD PhD, AlloVir (Consultant)Ansun Biopharma (Grant/Research Support)Astellas (Grant/Research Support)EvrysBio (Consultant, Other Financial or Material Support, Options to acquire equity, but have not exercised them)Gilead Sciences (Consultant, Grant/Research Support)GlaxoSmithKline (Consultant)Helocyte (Consultant, Other Financial or Material Support, Options to acquire equity, but have not exercised them)Janssen (Grant/Research Support)Kyorin (Consultant)Merck (Consultant, Grant/Research Support)Moderna (Consultant)Symbio (Consultant)Takeda (formerly known as Shire) (Consultant, Grant/Research Support)VirBio (Consultant, Grant/Research Support)…”
Enlace del recurso
Enlace del recurso

“…[Figure: see text] DISCLOSURES: Kaatz:  Gilead: Consultancy; Novartis: Consultancy; CSL Behring: Consultancy; Bristol Myer Squibb: Consultancy, Research Funding; Alexion: Consultancy; Pfizer: Consultancy; Janssen: Consultancy, Research Funding; Osmosis Research: Research Funding.…”
Enlace del recurso
Enlace del recurso

“…We included 78 vaccine-specific vaccine efficacy or effectiveness evaluations (Pfizer–BioNTech-Comirnaty, n=38; Moderna-mRNA-1273, n=23; Janssen-Ad26.COV2.S, n=9; and AstraZeneca-Vaxzevria, n=8). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To describe cases and incidence of GBS following COVID-19 vaccination and assess the risk of GBS after vaccination for Ad.26.COV2.S (Janssen) and mRNA vaccines. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used surveillance data from the Vaccine Safety Datalink at 8 participating integrated health care systems in the United States. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Marty, MD, SM, AlloVir: Advisor/Consultant|Amplyx: Advisor/Consultant|Amplyx: Grant/Research Support|Ansun: Grant/Research Support|Avir: Advisor/Consultant|Chimerix: Grant/Research Support|Cidara: Grant/Research Support|F2G: Advisor/Consultant|F2G: Grant/Research Support|Gilead: Grant/Research Support|Janssen: Advisor/Consultant|Kyorin: Advisor/Consultant|Merck: Advisor/Consultant|Merck: Grant/Research Support|Regeneron: Advisor/Consultant|Regeneron: Grant/Research Support|ReViral: Advisor/Consultant|Scynexis: Grant/Research Support|Symbio: Advisor/Consultant|Takeda: Grant/Research Support|United Medical: Advisor/Consultant|WHISCO: Grant/Research Support.…”
Enlace del recurso
Enlace del recurso

“…Cependant, en avril 2021, plusieurs études ont décrit des cas de thrombopénie associée à des thromboses après les vaccins ChAdOx1 nCov-19 et Ad26.COV2.S (vaccin Johnson & Johnson/Janssen). Ce syndrome rare a été nommé VITT pour vaccine-induced immune thrombotic thrombocytopenia et se caractérise par l’association d’une thrombopénie, d’une thrombose après une vaccination anti-COVID-19 associée à la présence d’anticorps activateurs de plaquettes contre le facteur plaquettaire 4 (PF4). …”
Enlace del recurso
Enlace del recurso

“…Deslandres Speakers bureau of: moderator and speaker Abbvie and Janssen…”
Enlace del recurso
Enlace del recurso

“…C.H. Gravholt: None. D. Hansen: None. Background: Congenital adrenal hyperplasia (CAH) due to 21 hydroxylase deficiency (21OHD) is a common autosomal recessive disorder caused by pathogenic variants in CYP21A2. …”
Enlace del recurso
Enlace del recurso

“…[Figure: see text] [Figure: see text] DISCLOSURES: Svenn Hansen, n/a, F. Hoffman La Roche: Employee|F. Hoffman La Roche: Stocks/Bonds Shih-Chen Cheng, M.S., P.h.D, Genentech/F. …”
Enlace del recurso
Enlace del recurso

“…Sputum samples were cultured at Armauer Hansen Research Institute (AHRI) TB laboratory, and drug susceptibility testing (DST) was performed against Isoniazid, Rifampicin, Ethambutol, and Streptomycin using the indirect proportion method. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…But, most influential association became European Federation for Medical Informatics (EFMI), established on September 11th 1976 in Copenhagen with members of 10 national representatives (Barry Barber (UK), Antonio Perens de Talens (Italy), Francois Grémy (France), Rolf Hansen (Norway), Mogens Jorgensen (Denmark), Hans Peterson (Sweden), Peter Leo Reichertz (Germany), Jan Roukens (Netherlands), Jan van Egmond (Belgium) and Ilkka Vaananen (Finland) who adopted Statute of EFMI and other documents and prepared the first MIE Conference in Cambridge (UK) in 1978. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Citation: Kosonen T, Huhtinen S, Hansen K. 2021. Taxonomy and systematics of Hyaloscyphaceae and Arachnopezizaceae. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cassaday, MD, Autolus: Independent response review committee|Kite/Gilead: Grant/Research Support|Kite/Gilead: Honoraria Jordan Gauthier, MD, Angiocrine Bioscience: Grant/Research Support|Celgene (a BMS company): Grant/Research Support|Century Therapeutics: Independent Data Review Committee|Janssen: Advisor/Consultant|Janssen: Honoraria|Juno Therapeutics (a BMS company): Grant/Research Support|Kite Pharma: Advisor/Consultant|Kite Pharma: Honoraria|Legend Biotech: Advisor/Consultant|Legend Biotech: Honoraria|MorphoSys: Advisor/Consultant|MorphoSys: Honoraria|Sobi: Advisor/Consultant|Sobi: Grant/Research Support|Sobi: Honoraria David G. …”
Enlace del recurso
Enlace del recurso

“…Molitch: Consulting Fee; Self; Amryt, Takeda, Sention, Janssen Research & Development Company. BACKGROUND: The Management of Acromegaly (MACRO) registry is a prospective, observational cohort study of patients with active acromegaly on medical therapy or eligible for medical therapy that includes paired data from patients and their physicians allowing for comparison of symptom-related data. …”
Enlace del recurso
Enlace del recurso

“…Rebeiro, PhD, MS, Gilead: Advisor/Consultant|Janssen Pharmaceuticals: Advisor/Consultant|National Institutes of Health: Grant/Research Support…”
Enlace del recurso
Enlace del recurso

“…DISCLOSURES: Michael Morris, MD, Janssen Pharmaceuticals: Paid speaker (unrelated to this project and COVID-19 in general) Ryan C. …”
Enlace del recurso
Enlace del recurso